Guidelines: Clinical Guidelines (Belgium): Difference between revisions
m (Update categories.) |
m (Update categories.) |
||
| Line 39: | Line 39: | ||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | ||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | <span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | ||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
Revision as of 12:12, 6 December 2025
Go back to Belgium page
Primary purpose: To assist national care providers in cancer patient care by adapting international best practices to the Belgian context.
Sponsor, manager or home institution: Belgian Board of Oncology.
Type of information: Provides detailed information on clinical practice guidelines for various cancer types, including topics like screening, diagnosis, treatment, supportive therapy, follow-up, and the role of general practitioners, specifically adapted to the Belgian context. diagnosis, medical procedures, palliative care, tumour histology, tumour staging, cancer incidence, age, sex, region. Click here to learn more.
Cancer areas of interest: C00-C97: All cancer types. Click here to learn more.
Access to information: Click here to access.
